¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"primary bile acid"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
  • linolenic acid
    ¸®³î·»»ê
  • linolic acid
    ¸®³î»ê
  • lipoic acid
    ¸®Æ÷»ê
  • lactic acid
    Á¥»ê
  • mixed acid
    È¥ÇÕ»ê
  • maleic acid
    ¸»·¹»ê
  • malic acid
    ¸»»ê
  • mucic acid
    ¹Â½Å»ê
  • muramic acid
    ¹Â¶ó¹Í»ê
  • mycolic acid
    ¹ÌÄÝ»ê
  • malonic acid
    ¸»·Ð»ê
  • myristic acid
    ¹Ì¸®½ºÆ¾»ê
  • mandelic acid
    ¸¸µ¨»ê
  • methacrylic acid
    ¸ÞŸũ¸±»ê
  • methylhippuric acid
    ¸ÞÆ¿È÷Ǫ¸£»ê
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
  • normal fatty acid
    Ç¥ÁØÁö¹æ»ê
  • nucleic acid
    ÇÙ»ê
  • oleic acid
    ¿Ã·¹»ê
  • organic acid
    À¯±â»ê
  • oxalic acid
    ¿Á»ì»ê
  • oxaloacetic acid
    ¿Á»ì¾Æ¼¼Æ®»ê
  • pantoic acid
    ÆÇÅäÀλê
  • pantothenic acid
    ÆÇÅäÅÙ»ê
  • phenolic acid
    Æä³î»ê
  • phenolsulfuric acid
    Æä³îȲ»ê
  • phenylpyruvic acid
    Æä´ÒÇÇ·çºê»ê
  • phosphopyruvic acid
    Æ÷½ºÆ÷ÇÇ·çºê»ê
  • picramic acid
    ÇÇÅ©¶÷»ê
  • propionic acid
    ÇÁ·ÎÇǿ»ê
  • pyridoxic acid
    ÇǸ®µ¶½Å»ê
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
  • amyloidosis primary
    ¿ø¹ß¼º(ê«Û¡àõ) ¾Æ¹Ð·ÎÀ̵åÁõ.
  • immune response, primary
    ÀÏÂ÷¸é¿ª¹ÝÀÀ
  • immunodeficiency syndrome, primary
    ÀÏÂ÷¼º ¸é¿ª°áÇÌ ÁõÈıº, ¿ø¹ß¼º ¸é¿ª°áÇÌ ÁõÈıº
  • infection, primary
    ÀÏÂ÷°¨¿°
  • interaction, primary
    ÀÏÂ÷»óÈ£ÀÛ¿ë
  • pneumonia, primary atypical
    ¿ø¹ß¼º ºñÁ¤ÇüÆó·Å
  • premaxilla [primary palate]
    ¾ÕÀ§ÅλÀ (ÀÏÂ÷ÀÔõÀå)
  • primary
    ¿ø¹ß¼º(ê«Û¡àõ)ÀÇ
  • primary (pain) neuron
    ÀÏÂ÷(Åë)´º¿ì·Ð.
  • primary (pain) neuron
    ÀÏÂ÷(Åë)´º¿ì·Ð.
  • primary abdominal implantation
    ÀÏÂ÷¹è¾ÈÂø»ó
  • primary acquired cholesteatoma
    ÀÏÂ÷(¼º) ÈÄõ(¼º) ÁøÁÖÁ¾
  • primary action
    ÀÏÂ÷±â´É
  • primary action; main action
    ÁÖÀÛ¿ë, ÀÏÂ÷ÀÛ¿ë.
  • primary adaptation
    ÀÏÂ÷(¼º) ¼øÀÀ(ìéó­àõâ÷ëë).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
  • primary immunodeficiency syndrome
    ¿ø¹ß¼º ¸é¿ª°áÇÌ ÁõÈıº
  • primary impression
    ÀÏÂ÷Àλó(¡­ìÔßÚ).
  • primary inclusion
    ÀÏÂ÷ºÀÀÔü(ÀÏÂ÷ºÀÀÔü).
  • primary infection
    ÀÏÂ÷°¨¿°
  • primary infiltration
    ÃʱâħÀ±
  • primary inoculation complex
    ¿ø¹ß¼º Á¢Á¾ º¹ÇÕü
  • primary insanity
    ¿ø¹ß(¼º) Á¤½Åº´(ê«Û¡àõïñãêÜ»).
  • primary insomnia
    ÀÏÂ÷¼º¡¡ºÒ¸éÁõ
  • primary integration
    ¼Ò¾ÆÀÏÂ÷¼º ÀÚ±âÀνÄ(á³ä®ìéó­àõí»ÐùìããÛ).
  • primary ionization
    ÀÏÂ÷ÀÌ¿ÂÈ­.
  • primary irritant dermatitis
  • primary irritation
    ÀÏÂ÷ÀÚ±Ø(¡­ô§Ð½).
  • primary lateral sclerosis
    ¿ø¹ß(¼º) Ãø»è°æÈ­(Áõ)(¡­ö°ßãÌãûùñø).
  • primary lateral sclerosis
    ¿ø¹ß(¼º) Ãø»è°æÈ­(Áõ)(ê«Û¡(àõ) ö°ßãÌãûùñø)
  • primary lens fiber
    ÀÏÂ÷¼öÁ¤Ã¼¼¶À¯(ìéó­â©ïÜô÷àéë«).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
  • guanylic acid
    ±¸¾Æ´Ò»ê(ß«)
  • helix-breaking amino acid
    ³ª¼±(Õ¢àÁ) ±ú±â ¾Æ¹Ì³ë»ê(ß«)
  • heterofermentative lactic acid bacteria
    ÀÌÁ¾¹ßÈ¿(ì¶ðúÛ£ý£) ¶ôÆ®»ê(ß«) ¹ÚÅ׸®¾Æ
  • hexuronic acid
    Çí½´·Ð »ê(ß«)
  • hippuric acid
    ¸¶´¢»ê(Ø©Òãß«)
  • homoamino acid
    È£¸ð¾Æ¹Ì³ë»ê(ß«)
  • homocodonic amino acid
    ±Õ(г)ÄÚµ· ¾Æ¹Ì³ë»ê(ß«)
  • homofermentative lactic acid bacteria
    µ¿Á¾¹ßÈ¿(ÔÒðúÛ£ý£) ¶ôÆ®»ê(ß«) ¹ÚÅ׸®¾Æ
  • homogentisic acid
    È£¸ðÁ¨Æ¾»ê(ß«)
  • hyaluronic acid
    ÇÏÀ̾ËÀ¯·Ð»ê(ß«)
  • hydroxy acid
    ÇÏÀ̵å·Ï½Ã»ê(ß«)
  • ¥â-hydroxybutyric acid
    ¥â-ÇÏÀ̵å·Ï½ÃºäƼ¸£»ê(ß«)
  • 5-hydroxyindoleacetic acid
    5-ÇÏÀ̵å·Ï½ÃÀε¹¾Æ¼¼Æ®»ê(ß«)
  • imino acid
    À̹̳ë»ê(ß«)
  • indispensable amino acid
    ºÒ°¡°á(ÝÕʦÌÀ) ¾Æ¹Ì³ë»ê(ß«)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 14
BAO-MAO basal acid output to maximal acid output [ratio]
cDNA circular deoxyribonucleic acid; complementary deoxyribonucleic acid
DPA D-penicillamine; Department of Public Assistance; diphenylalanine; dipicolinic acid; dipropylacetic ...
EAA electroacupuncture analgesia; Epilepsy Association of America; essential amino acid; excitatory amin...
FAA folic acid antagonist; formaldehyde, acetic acid, alcohol
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 14
PA Primary aldosteronism
PACNS Primary angiitis of the central nervous system
PCP primary care provider
PCL Primary cerebral lymphoma
pCBCL Primary cutaneous B cell lymphomas
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • kinotannic acid
    Ű³ëź´Ñ»ê
  • laccainic acid
    ¶óÄ«ÀÎ »ê
    Àû°¥»öÀÇ °áÁ¤ »ê.
  • laccic acid
    ¶óÅ© »ê
    ¶óÅ© ¿°·á¿¡¼­ ¾ò´Â Àû°¥»öÀÇ °áÁ¤¹°.
  • lactic acid
    À¯»ê
    Ä«¸£º¹½Ã±â, ¼ö»ê±â, ¸ÞÆ¿±â, ¼ö¼ÒÀÇ ³× ¿øÀÚ´ÜÀÌ °áÇÕÇÑ ºñ´ëĪ ź¼Ò ¿øÀÚ¸¦ °¡Áö´Â À¯±âÈ­ÇÕ¹°. È÷µå·Ï½Ã ÇÁ·ÎÇǿ»ê, ¶ôÆ®»ê, À¯»êÀ̶ó°íµµ ÇÑ´Ù. 1780³â K.W. ¼Ð·¹¿¡ ÀÇÇØ »êÆÐÇÑ ¿ìÀ¯ ¼Ó¿¡¼­ ¹ß°ßµÇ¾úÀ¸¸ç µ¿½Ä¹°°è¿¡ ³Î¸® Á¸ÀçÇÑ´Ù. D, L, DLÇüÀÇ ±¤ÇÐ À̼ºÁúü°¡ ÀÖ´Ù. L-Á¥»êÀº ÇØ´ç °úÁ¤ÀÇ ÃÖÁ¾ »ê¹°·Î¼­ ÇÇ·çºê»êÀÇ È¯¿ø¿¡ ÀÇÇØ »ý¼ºµÈ´Ù. Á¶ÇؼºÀÌ °­ÇÑ ÁÖ»ó °áÁ¤À̸ç, ³ì´ÂÁ¡Àº 25¡­26 ¡ÉÀÌ´Ù. ±ÙÀ°, µ¿¹°Á¶Á÷ ¼Ó¿¡ Á¸ÀçÇÏ¸ç »ç¶÷ÀÇ Ç÷¾× ¼Ó¿¡´Â 100 m§¤´ç 5¡­20 mgÀÌ Á¸ÀçÇϸç, ½ÉÇÑ ¿îµ¿¿¡ ÀÇÇØ Áõ°¡ÇÑ´Ù. ¿îµ¿¿¡ ÀÇÇÑ ±ÙÀ°ÀÇ ÇǷδ ±Û¸®ÄÚ°ÕÀÇ ºÐÇØ¿¡ ÀÇÇÑ L-Á¥»êÀÇ ÃàÀû°ú °ü°è°¡ ÀÖ´Ù. ÈÞ½Ä ½Ã¿¡´Â ±× ÀϺΰ¡ »êÈ­ ºÐÇØµÇÁö¸¸ ´ëºÎºÐ ¿ø·¡ÀÇ ±Û¸®ÄÚ°ÕÀ¸·Î ÀçÇÕ¼ºµÈ´Ù. D-Á¥»êÀº µÎ²¨¿î ÆÇ»ó °áÁ¤À̸ç, ³ì´ÂÁ¡Àº 26¡­27 ¡ÉÀÌ´Ù. DL-Á¥»ê
  • lactic acid bacteria
    Á¥»ê ±Õ
    ±Û·çÄÚ¿À½º µî ´ç·ù¸¦ ºÐÇØÇÏ¿© Á¥»êÀ» »ý¼ºÇÏ´Â ¼¼±Õ. ¶ôÆ®»ê±Õ, À¯»ê ±ÕÀ̶ó°íµµ ÇÑ´Ù. Á¥»ê ¹ßÈ¿¿¡ ÀÇÇØ »ý¼ºµÇ´Â Á¥»ê¿¡ ÀÇÇØ¼­ º´¿ø ±Õ°ú À¯ÇØ ¼¼±ÕÀÇ »ýÀ°ÀÌ ÀúÁöµÇ´Â ¼ºÁúÀ» À¯Á¦Ç°
  • lactic acid bacterium
    ¶ôÆ® ±Õ
  • lactic acid formation
    À¯»ê Çü¼º
  • lactonic acid
    ¶ôÅæ »ê
    À¯´ç. ¾Æ¶óºñ¾Æ °í¹«. °¥¶ôÅ佺¸¦ »êÈ­ÇÔÀ¸·Î½á ¾ò¾îÁø´Ù.
  • lanopalmic acid : ¾ç¸ðÁö¿¡ µé¾î ÀÖ´Â 1¼ö»ê±â¼ºÀÇ Æ÷È­ Áö¹æ»ê.

    lanosterol

    ¶ó³ë½ºÅ×·Ñ
    ¾ç¸ðÁö¿¡ µé¾î ÀÖ´Â ½ºÅ×·ÑÀÇ ÀÏÁ¾.
  • larinolic acid
    ¶ó¸®³î »ê
  • linolic acid
    ¸®³î»ê
  • lymphocantric acid
    ¸²Æ÷Ä­Æ®¸£»ê
    Àӯļº ¹éÇ÷º´ ȯÀÚÀÇ ¿ä¿¡¼­ ÃßÃâµÈ´Ù.
  • lysalbinic acid
    ¸®»ìºó »ê
    ³­¹éÀ» °¡¼º ¼Ò¿À´Ù·Î ó¸®ÇÔÀ¸·Î½á ¾ò¾îÁö´Â »ê.
  • lysergic acid
    ¸®À縣±×»ê
    ¸Æ°¢ ¾ËÄ®·ÎÀ̵åÀÇ ¸ðü·Î, ±× À̼ºÃ¼ÀÎ ÀÌ¼Ò ¸®Á¦¸£±×»ê°ú ÇÔ²² Æ®¸®ÆéƼµå ¶Ç´Â ¾Æ¹Ì³ë ÇÁ·ÎÆÄ³î°ú °áÇÕÇÏ¿© ¸Æ°¢ ¾ËÄ®·ÎÀ̵å·ù¸¦ Çü¼ºÇÑ´Ù.
  • lyxonic acid
    ¸¯¼Õ»ê
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 14
dentition, primary The teeth first in order or time of development that will be replaced by permanent dentition upon their loss.
(12 Dec 1998)
dorsal primary ramus of spinal nerve <anatomy, nerve> The smaller, posteriorly-directed major terminal branch (with the ventral primary ramus) of all 31 pairs of mixed spinal nerves, formed at the intervertebral foramen and turning abruptly posteriorly to divide into lateral and medial branches, both of which will supply the deep (true) muscles of the back. The medial branch (rami medialis ) of the dorsal primary ramus also supplies articular branches to the zygopophyseal joints and the periosteum of the vertebral arch. In the neck and upper back, the medial branch continues through the deep and superficial back muscles to supply overlying skin; in the lower back, the lateral branch does this. Nomina Anatomica lists dorsal primary rami as "rami dorsales" for each group of spinal nerves: 1) cervical (nervorum cervicalium ), 2) thoracic (nervorum thoracicorum ), 3) lumbar (nervorum lumbalium ), 4) sacral (nervorum sacralium ), and 5) coccygeal (nervi coccygei ).
Synonym: ramus dorsalis nervorum spinalium, ramus dorsalis, rami posteriores nervorum spinalium, dorsal branch, posterior primary division.
(05 Mar 2000)
International Classification of Health Problems in Primary Care A classification of diseases, conditions and problems arranged for use in primary care where diagnostic precision is seldom possible.
(05 Mar 2000)
osteoarthropathy, primary hypertrophic A conditioned chiefly characterised by thickening of the skin of the head and distal extremities, deep folds and furrows of the skin of the forehead, cheeks, and scalp, seborrhoea, hyperhidrosis, periostosis of the long bones, digital clubbing, and spadelike enlargement of the hands and feet. It is more prevalent in the male, and is usually first evident during adolescence. It is believed to be inherited as an autosomal dominant trait.
(12 Dec 1998)
lateral cutaneous branches of ventral primary ramus of thoracic spinal nerves Branches arising in approximately the anterior axillary line at the level of the second through sixth intercostal spaces.
Synonym: rami mammarii laterales nervorum intercostalium, lateral cutaneous branches of intercostal nerves.
(05 Mar 2000)
a1-acid glycoprotein <biology> Plasma protein of mammals and birds, 38% carbohydrate. In humans a single chain glycoprotein of 39 kD. Increased levels are associated with inflammation, pregnancy and various diseases.
(18 Nov 1997)
abscisic acid <biochemistry> A lipid hormone that inhibits cell growth in plants, it is associated with fruit drop, leaf death and seed dormancy. It is synthesised in the plastids from carotenoids. This hormone helps plants deal with water loss, and its effects can be reversed with gibberellins.
(06 May 1997)
abscisic acid 8'-hydroxylase <enzyme> Catalyses conversion of abscisic acid to 8'-hydroxyabscisic acid, which rearranges to phaseic acid
Registry number: EC 1.14.99.-
Synonym: aba 8'-hydroxylase
(26 Jun 1999)
acetic acid <chemical> The acid most commonly associated with vinegar, it is the most commercially important organic acid and is used to manufacture a wide range of chemical products, such as plastics and Acetobacter but, except for making vinegar, is usually made through synthetic processes.
Derivatives of acetic acid which may be formed by substitution reactions. Mono- and di-substituted, as well as, halogenated compounds have been synthesised.
Experimentally, alpha- and n2- substituted acetic acids have been examined for their anti-inflammatory activity and effect on the central nervous system respectively. Additionally, limited exposure data has been collected on dibromo and dichloroacetic acids to determine whether they pose health effects.
Synonym: ethanoic acid.
(26 Jun 1999)
acetoacetic acid CH3COCH2COOH;one of the ketone bodies, formed in excess and appearing in the urine in starvation or diabetes.
Synonym: diacetic acid.
(05 Mar 2000)
acetohydroxamic acid C2H5NO2; N-Hydroxyacetamide;an inhibitor of urease, used as adjunctive therapy in chronic urea-splitting urinary infections.
(05 Mar 2000)
acetrizoic acid <chemical> A water-soluble, iodinated radiographic contrast medium, used as sodium acetrizoate in hysterosalpingography.
Pharmacological action: contrast media.
Chemical name: Benzoic acid, 3-(acetylamino)-2,4,6-triiodo-
(12 Dec 1998)
acetylsalicylic acid <drug> An odourless, white, slightly bitter drug used to reduce pain, fever, inflammation and sometimes to prevent blood clotting. Also called aspirin. Some people cannot tolerate it because it can cause stomach bleeding, however. It is soluble in both water and alcoholand melts at 132 to 136 degrees C.
(06 May 1997)
acetyltannic acid An astringent used for treatment of diarrhoea.
Synonym: diacetyltannic acid, tannylacetate.
(05 Mar 2000)
acid <chemical, chemistry> A fundamental category of many compounds whose water-based solutions have a sour taste, turn blue litmus paper red and can combine with metals to form salts.
They are chemical compounds which yield hydrogen ions or protons when dissolved in water, whose hydrogen can be replaced by metals or basic radicals, or which react with bases to form salts and water (neutralization).
An extension of the term includes substances dissolved in media other than water. Specific types of acids include:
Arrhenius acid: any chemical that increases the number of free hydrogen ions (H+) when added to a water-based solution. The more free hydrogens produced, the stronger the acid.
Bronsted or Bronsted-Lowry acid: any chemical that acts as a proton donor in a chemical reaction.
Lewis acid: any chemical that accepts two electrons to form a covalent bond during a chemical reaction.
(13 Nov 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 14
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 14
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 14
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 14
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 14
ÅëÇÕ°Ë»ö ¿Ï·á